Plasma Fractionation Market Growth Report - Size Outlook 2028
[Research Report] The plasma fractionation market is expected to grow to US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; the plasma fractionation market is estimated to grow with a CAGR of 6.3% from 2021-2028.
Analyst Perspective
The growth of global plasma fractionation market is expected to grow due to the rising use of plasma therapy for treating novel diseases and increasing applications of plasma to design therapeutic products. In addition, during the COVID-19 pandemic, the demand for plasma therapy has surged, which has leveraged the growth of the plasma fractionation market. Moreover, the growing incidences of autoimmune diseases, infectious diseases, and immune diseases have served as vital growth opportunities for the market’s growth. The enhanced knowledge about the advantages of plasma therapy has increased plasma fractionation in developed countries. At the same time, developing countries are putting efforts to enhance their abilities to derive plasma and expand the use of plasma therapy. For instance, according to the Indian Government, the country has over 2 700 blood banks that collect nearly 10–11 million blood units annually. However, the statistics show that there is often a short supply of plasma in the country, and compared to developed countries, the usage of plasma derivatives per capita is less. However, the growing awareness and increasing investments in plasma fractionation in developed countries have paved the way for the growth of plasma fractionation in the market during 2021–2028.
Market Overview
The process of separating various components of blood plasma is known as plasma fractionation. The separated components are used to create various therapeutic plasma products that can be used to treat various medical conditions. Immunoglobulin, coagulation factors, albumins, and inhibitors are just a few of the plasma products commonly used. The growth of the plasma fractionation market is mainly driven by the factors such as the increasing application of plasma therapy and the active participation of the player companies in market developments that are propelling the market growth. However, the availability of recombinant or non-plasma Products is hampering the growth of the market. The global plasma fractionation market is segmented on the basis of product, application, and end user. Based on geography, the market is classified into North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The North American region holds the largest market share of the plasma fractionation market, and Asia Pacific is estimated to be the fastest-growing region.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plasma Fractionation Market: Strategic Insights
Market Size Value in US$ 26,575.83 million in 2021 Market Size Value by US$ 40,731.98 million by 2028 Growth rate CAGR of 6.3% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Plasma Fractionation Market: Strategic Insights
| Market Size Value in | US$ 26,575.83 million in 2021 |
| Market Size Value by | US$ 40,731.98 million by 2028 |
| Growth rate | CAGR of 6.3% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Driver
Rising Application of Plasma Therapy
Blood plasma is among the emerging method for treating various chronic diseases. The plasma consists of essential components, such as proteins, albumin, globulins, fibrinogen, clotting factors and inhibitors, and others. It is widely used in blood cancer, COVID19, Atrial fibrillation, leukemia, and others. The plasma is separated from the donated blood by using plasma Fractionation. The regulatory agencies are also providing the required approvals for the use of plasma in treatment processes. For instance, in August 2020, the US Food and Drug Administration (USFDA) issued the emergency use authorization (EUA) for convalescent plasma treatment of COVID–19. In addition to this, in February 2021, the USFDA issued an updated guideline for the plasma EUA for COVID19. Thus, active involvement and approval by the regulatory and government are expected to encourage the application of blood plasma. The blood plasma can be stored for up to one year by freezing within 24 hours of blood donated to protect the valuable clotting factors and can be used post thawing process. Many blood bank settings are established in every country worldwide, have access to healthcare service providers, and are funded by various governments and other organizations. For instance, in 2021, the American Association of Blood Banks (AABB) granted funding for the research projects such as “Engineering Immunotherapy Resistant Hematopoiesis to Treat High-Risk Acute Myeloid Leukemia” (by Pietro Genovese, BSc, MSc, Ph.D., Assistant Professor in Pediatrics, Gene Therapy Program, Dana-Farber/Boston Children’s Cancer and Blood Disorder Center, Dana-Farber Cancer Institute), “New Approaches to Study and Treat Alloantibody-Mediated Diseases Resulting from Blood Transfusions” (by Simon J. Cleary, Ph.D.; Postdoctoral Fellow, Medicine-Pulmonary, University of California.) and others. Therefore, as per the above-stated factors, the blood plasma fractionation related market in the forecast period.
Segment Analysis
The global plasma fractionation market is segmented on the basis of product, application, and end user. Based on the product, the market is segmented into immunoglobulin, albumin, coagulation factor concentrates, protease inhibitors, and others. The immunoglobulin segment is likely to hold the largest share of the market in 2021. Moreover, it is anticipated to register the highest CAGR in the market during 2021–2028. This segment is expected to contribute considerably to the market in the forecast period owing to the increasing prevalence of infectious diseases and the active support of the government and regulatory agencies in product developments and approvals. For instance, in May 2021, the US Food and Drug Administration (FDA) issued an emergency use authorization for the investigational monoclonal antibody therapy 'Sotrovimab' to treat mild-to-moderate COVID-19 in adults and pediatric patients. Further, the immunoglobulin is subsegmented into intravenous immunoglobulin, subcutaneous, and others.
Based on the application, the market is segmented into neurology, immunology, hematology, critical care, pulmonology, and others. In 2021, the neurology segment held the largest market share of the plasma fractionation market. However, the hematology segment is expected to witness growth at the fastest CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe.
Based on the end user, the market is segmented into hospitals and clinics, clinical research laboratories, and academic institutes. In 2021, the hospitals and clinics segment is likely to hold the largest share of the market. Moreover, the clinical research laboratories segment is also expected to witness growth in its demand at the fastest CAGR from 2021 to 2028, owing to the rise in the detection and diagnosis of various medical conditions across the globe.
Regional Analysis
North America held the largest market share of the global plasma fractionation market, valued at US$ 9,484.91 million in 2021 and estimated to grow at a CAGR of 6.5% from 2021–2028. The North American plasma fractionation market is divided into the US, Canada, and Mexico. The growth of the market in the region is widely attributed to the growing application of coagulation factor concentrates, clotting factor concentrates, and other plasma-derived products to treat various hematological disorders such as hemophilia A, hemophilia B. Moreover, the growth of the market in Canada is expected to grow due to the increasing prevalence of multiple sclerosis and other neurological disorders. In addition, in Mexico, the market is estimated to grow owing to increasing awareness about blood and related disorders and immunological disorders, along with rising awareness about plasma-derived therapies in the treatment of chronic disorders. On the other hand, the Asia Pacific is expected to grow at the fastest CAGR during 2021 to 2028. The growth of the market in the region is attributed to the growing interest of international players in China and India, government support in countries such as China, and advancing healthcare infrastructure. Therefore, the region holds huge potential for the plasma fractionation market players to grow during the forecast period.
Key Player Analysis
The plasma fractionation market majorly consists of the players such as Bio Products Laboratory LTD, CSL Limited, Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Grifols S.A, Kedrion, SK Plasma, Plasmagen Biosciences PVT. LTD, Octapharma AG, amongst others. The two leading players in the market are CSL Limited and Grifols S.A. These companies are involved in various organic and inorganic developments that have paved the way for significant growth opportunities.
Plasma Fractionation Market Report Scope
Recent Developments
Companies in the plasma fractionation market highly adopt inorganic and organic strategies. A few recent key market developments are listed below:
- In April 2020, Grifols, a global manufacturer of plasma-derived medicines, announced the launch of a new 3-mL vial of HyperRAB, which is used to treat postexposure prophylaxis for rabies. The US Food and Drug Administration had already approved this vial in 2019.
- In May 2021, Liminal BioSciences Entered into an Agreement with Kedrion to Divest Its Plasma Collection and Plasma-Derived Therapeutics Business.
- In April 2021, BPL and Atlantic Research Group entered into a long-term collaboration. This agreement establishes ARG as BPL's preferred contract research organization (CRO) for conducting clinical research trials and providing supportive services for the company's global new product development programs. The agreement builds on BPL and ARG's previous successful collaboration on clinical trial programs.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, RoAPAC, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The global plasma fractionation market is being driven by factors such rising application of plasma therapy and active participation of the players in market developments, development potential in emerging countries are likely to offer significant opportunities for the growth of the global plasma fractionation market.
The Asia Pacific is expected to be the fastest-growing region in the plasma fractionation market. The growth of the market in this region is primarily due to the rising application of plasma therapy and the active participation of the players in market developments
The process of separating various components of blood plasma is known as plasma fractionation. The separated components are used to create a variety of therapeutic plasma products that can be used to treat a variety of medical conditions. Immunoglobulin, coagulation factors, albumins, and inhibitors are just a few of the plasma products commonly used.
The availability of non-plasma products is the significant factor that will hinder the plasma fractionation market growth.
The market players in the global market in constantly involved in the product development and innovations as part of their business strategies such as product launch, mergers and acquisitions, partnership and others. For instance, in July 2020, Grifols has entered into purchase agreements with South Korean-based GC Pharma (Group) through which the company would buy a plasma fractionation plant and two purification facilities in Montreal and 11 plasma collection locations in the United States, a total of US$460 million.
The key players in the global plasma fractionation are Bio Products Laboratory LTD, CSL Limited, Biotest AG, Sanquin, Bharat Serums and Vaccines Limited, Grifols S.A, Kedrion, SK Plasma, Plasmagen Biosciences PVT. LTD, Octapharma AG and among others.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Plasma Fractionation Market – By Product
1.3.2 Global Plasma Fractionation Market – By Application
1.3.3 Global Plasma Fractionation Market – By End User
1.3.4 Global Plasma Fractionation Market – By Geography
2. Global Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe– PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Experts Opinion
5. Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Application of Plasma Therapy
5.1.2 Active Participation of the Players in Market Developments
5.2 Market Restraints
5.2.1 Availability of Non-Plasma Products
5.3 Market Opportunities
5.3.1 Development Potential in Emerging Countries
5.4 Future Trends
5.4.1 Use of Plasma Therapy for Treating Novel Diseases
5.5 Impact Analysis
6. Plasma Fractionation Market – Global Analysis
6.1 Global Plasma Fractionation Market Revenue Forecast and Analysis
6.2 Global Plasma Fractionation Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 Global Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin : Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
8. Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 Global Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 Global Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. Plasma Fractionation Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Plasma Fractionation Market
10.1.1 Overview
10.1.2 North America: Plasma Fractionation Market - Revenue and Forecast to 2028 (USD Million)
10.1.3 North America Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.3.1 North America Plasma Fractionation Market, by immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.1.4 North America Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3 US Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.3.1 US Plasma Fractionation Market, by immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.5 US Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3 Canada Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.3.1 Canada Plasma Fractionation Market, by immunoglobulin type– Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.5 Canada Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3 Mexico Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.3.1 Mexico Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.5 Mexico Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Plasma Fractionation Market
10.2.1 Overview
10.2.2 Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.3 Europe: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (USD Million)
10.2.3.1 Europe: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.2.4 Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.5 Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6 Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Overview
10.2.6.1.2 Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3 Germany: Plasma Fractionation Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.3.1 Germany: Plasma Fractionation Market, by Immunoglobulin type– Revenue and Forecast to 2028 (USD Million)
10.2.6.1.4 Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.5 Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 Overview
10.2.6.2.2 France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3 France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.3.1 France: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.4 France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.5 France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Overview
10.2.6.3.2 UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3 UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.3.1 UK: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.4 UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.5 UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Overview
10.2.6.4.2 Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3 Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.3.1 Spain: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.4 Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.5 Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 Overview
10.2.6.5.2 Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3 Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.3.1 Italy: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.4 Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.5 Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Overview
10.2.6.6.2 Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.4 Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.5 Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.3 Asia Pacific Plasma Fractionation Market Revenue And Forecasts To 2028
10.3.1 Overview
10.3.2 Asia Pacific Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.3 Asia Pacific: Plasma Fractionation Market Revenue And Forecasts to 2028, By Productt (US$ Mn)
10.3.3.1 Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
10.3.4 Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By Application (US$ Mn)
10.3.5 Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6 Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 Japan: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.1.1 Overview
10.3.6.1.2 Japan: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.1.3 Japan Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
10.3.6.1.3.1 Japan: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
10.3.6.1.4 Japan: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
10.3.6.1.5 Japan: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.2 China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.2.1 Overview
10.3.6.2.2 China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.2.3 China: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
10.3.6.2.3.1 China: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
10.3.6.2.4 China: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
10.3.6.2.5 China: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.3 India Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.3.1 Overview
10.3.6.3.2 India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.3.3 India: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
10.3.6.3.3.1 India: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
10.3.6.3.4 India: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
10.3.6.3.5 India: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.4 South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.4.1 Overview
10.3.6.4.2 South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.4.3 South Korea: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
10.3.6.4.3.1 South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
10.3.6.4.4 South Korea: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
10.3.6.4.5 South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.5 Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.5.1 Overview
10.3.6.5.2 Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
10.3.6.5.3 Australia: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
10.3.6.5.3.1 Australia: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
10.3.6.5.4 Australia: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
10.3.6.5.5 Australia: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.3.6.6 Rest of Asia Pacific: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Overview
10.3.6.6.2 Rest of Asia Pacific: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
10.3.6.6.3.1 Rest of Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
10.3.6.6.4 Rest of Asia Pacific: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
10.3.6.6.4.1 Rest of Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
10.4 Middle East & Africa Plasma Fractionation Market Revenue and Forecasts To 2028
10.4.1 Overview
10.4.2 Middle East & Africa Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.3 Middle East & Africa: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.3.1 Middle East & Africa: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.4.4 Middle East & Africa: Plasma Fractionation Market Revenue and Forecasts to 2028, By Application(US$ Mn)
10.4.4.1 Middle East & Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.5 Middle East & Africa Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)
10.4.5.1 UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.1.1 Overview
10.4.5.1.2 UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.1.3 UAE: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.1.3.1 UAE: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.4.5.1.4 UAE: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application(US$ Mn)
10.4.5.1.4.1 UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.5.2 Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.2.1 Overview
10.4.5.2.2 Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.2.3 Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.2.3.1 Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.4.5.2.4 Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application(US$ Mn)
10.4.5.2.5 Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.5.3 South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.3.1 Overview
10.4.5.3.2 South Africa Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.3.3 South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.3.3.1 South Africa: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.4.5.3.4 South Africa: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application(US$ Mn)
10.4.5.3.4.1 South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.4.5.4 Rest of Middle East and Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.1 Overview
10.4.5.4.2 Rest of Middle East and Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
10.4.5.4.3 Rest of Middle East & Africa: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
10.4.5.4.3.1 Rest of Middle East & Africa: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)
10.4.5.4.4 Rest of Middle East & Africa: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application(US$ Mn)
10.4.5.4.5 Rest of Middle East and Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Plasma Fractionation Market
10.5.1 Overview
10.5.2 South and Central America: Plasma Fractionation Market- Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.3.1 South and Central America: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.5.4 South and Central America: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.5 South and Central America: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6 South and Central America Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Overview
10.5.6.1.2 Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3 Brazil: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.3.1 Brazil: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.4 Brazil: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.5 Brazil: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2 Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Overview
10.5.6.2.2 Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3 Argentina: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.3.1 Argentina: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.4 Argentina: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.5 Argentina: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3 Rest of South and Central America: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Overview
10.5.6.3.2 Rest of South and Central America: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3 Rest of South and Central America: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.3.1 Rest of South and Central America: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.4 Rest of South and Central America: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.5 Rest of South and Central America: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Plasma Fractionation Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment Of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
11.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies done by the companies in the Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Biotest AG.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Octapharma AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Kedrion S.p.A
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CSL Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Grifols, S.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio Products Laboratory Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sanquin
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bharat Serums and Vaccines Limited (BSV)
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 SK Plasma
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 PlasmaGen BioSciences Pvt. Ltd.
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 2. North America Plasma Fractionation Market, by immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. US Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 6. US Plasma Fractionation Market, by immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 7. US Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 8. US Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Plasma Fractionation Market, by Product - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Plasma Fractionation Market, by immunoglobulin type - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Plasma Fractionation Market, By Application - Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico Plasma Fractionation Market, By Application – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 19. Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Germany: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Germany: Plasma Fractionation Market, by Immunoglobulin type– Revenue and Forecast to 2028 (USD Million)
Table 23. Germany: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. France: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 26. France: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 27. France: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 28. France: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. UK: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 30. UK: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 31. UK: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 32. UK: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 33. Spain: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 34. Spain: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 35. Spain: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 36. Spain: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 38. Italy: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 39. Italy: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 40. Italy: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Rest of Europe: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 43. Rest of Europe: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 45. Asia Pacific: Plasma Fractionation Market Revenue And Forecasts to 2028, By Productt (US$ Mn)
Table 46. Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
Table 47. Asia Pacific: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
Table 48. Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 49. Japan Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
Table 50. Japan: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
Table 51. Japan: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
Table 52. Japan: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 53. China: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
Table 54. China: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
Table 55. China: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
Table 56. China: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 57. India: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
Table 58. India: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
Table 59. India: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
Table 60. India: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 61. South Korea: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
Table 62. South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
Table 63. South Korea: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
Table 64. South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 65. Australia: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
Table 66. Australia: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
Table 67. Australia: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
Table 68. Australia: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 69. Rest of Asia Pacific: Plasma Fractionation Market Revenue And Forecasts to 2028, By Product (US$ Mn)
Table 70. Rest of Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By Immunoglobulin Type (US$ Mn)
Table 71. Rest of Asia Pacific: Plasma Fractionation Market Revenue And Forecasts to 2028, By Application (US$ Mn)
Table 72. Rest of Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By End User (US$ Mn)
Table 73. Middle East & Africa: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 74. Middle East & Africa: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 75. Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application(US$ Mn)
Table 76. Middle East & Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 77. UAE: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 78. UAE: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 79. UAE: Plasma Fractionation Market Revenue and Forecasts to 2028, By Application(US$ Mn)
Table 80. UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 81. Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 82. Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 83. Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028, By Application(US$ Mn)
Table 84. Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 85. South Africa Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 86. South Africa: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 87. South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application(US$ Mn)
Table 88. South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Middle East & Africa: Plasma Fractionation Market Revenue and Forecasts to 2028, By Product (US$ Mn)
Table 90. Rest of Middle East & Africa: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Middle East & Africa: Metabolomics Market Revenue and Forecasts to 2028, By Application(US$ Mn)
Table 92. Rest of Middle East and Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)
Table 93. South and Central America: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 94. South and Central America: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 95. South and Central America: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 96. South and Central America: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 97. Brazil: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 98. Brazil: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 99. Brazil: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 101. Argentina: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 102. Argentina: Plasma Fractionation Market, by Immunoglobulin type– Revenue and Forecast to 2028 (USD Million)
Table 103. Argentina: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 105. Rest of South and Central America: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of South and Central America: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South and Central America: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South and Central America: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 109. Organic Developments Done By Companies
Table 110. Inorganic developments done by Companies
Table 111. Glossary of Terms, Plasma Fractionation Market
LIST OF FIGURES
Figure 1. Plasma Fractionation Market Segmentation
Figure 2. Plasma Fractionation Market Segmentation, By Region
Figure 3. Global Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in Plasma Fractionation Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Plasma Fractionation Market, by Geography (US$ Million)
Figure 7. Global Plasma Fractionation Market – Leading Country Markets (US$ Million)
Figure 8. Global Plasma Fractionation Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe and PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Impact Analysis of Drivers and Restraints Pertaining to Plasma Fractionation Market
Figure 15. Global Plasma Fractionation Market – Revenue Forecast and Analysis – 2020- 2028
Figure 16. Global Plasma Fractionation Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Market Positioning of Key Players in Global Plasma Fractionation Market
Figure 18. Global Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 19. Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 20. Intravenous Immunoglobulin : Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 21. Intravenous Immunoglobulin : Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 22. Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 23. Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 24. Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 25. Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 26. Global Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 27. Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 29. Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 30. Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 31. Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 32. Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 33. Global Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 34. Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 35. Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 36. Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 37. North America: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 38. North America Plasma Fractionation Market Revenue and Forecast to 2028 (USD Million)
Figure 39. North America: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 40. US: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 41. Canada: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 42. Mexico: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 43. Europe: Plasma Fractionation Market, by Key Country – Revenue (2021) (USD Million)
Figure 44. Europe: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Million)
Figure 45. Europe: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 46. Germany: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 47. France: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 48. UK: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 49. Spain: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 51. Rest of Europe: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific Plasma Fractionation Market Overview, by Country (2018)
Figure 53. Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 54. Asia Pacific: Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)
Figure 55. Japan: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 56. China: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 57. India: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 58. South Korea: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 59. Australia: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 60. Rest of Asia Pacific: Plasma Fractionation Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Middle East & Africa Plasma Fractionation Market Revenue Overview, by Country, 2021 (US$ Mn)
Figure 62. Middle East & Africa Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 63. Middle East & Africa Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)
Figure 64. UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 65. Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 66. South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 67. Rest of Middle East and Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 68. South and Central America: Plasma Fractionation Market, By Key Country – Revenue (2021) (USD Million)
Figure 69. South and Central America: Plasma Fractionation Market- Revenue and Forecasts To 2028 (USD Million)
Figure 70. South and Central America: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 71. Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 72. Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 73. Rest of South and Central America: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 74. Impact of COVID-19 Pandemic in North American Country Markets
Figure 75. Impact of COVID-19 Pandemic in European Country Markets
Figure 76. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 77. Impact of COVID-19 Pandemic in South & Central America Market
Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 79. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 80. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 81. Growth Strategies done by the companies in the Market (%)
The List of Companies - Plasma Fractionation Market
- BASF SE
- TMIC
- Creative Proteomics
- BGI
- RTI International
- Afekta Technologies Ltd.
- Fred Hutchinson Cancer Research Center
- West Coast Metabolomics Center
- Molecular You
- Metabolon, Inc.
- biocrates life sciences ag
- Chenomx Inc.
- C-CAMP
- metaSysX
- MS-Omics
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For